Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRILIPIX
- Fenofibrate in Type 2 Diabetes
- CKD-337(2) Drug-drug Interaction Study
- Medication Development in Alcoholism: Investigating PPAR Agonists
- AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
- Study of Trilipix Effects on Lipids and Arteries
- Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
- Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
- Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
- Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
Clinical trials list
click for details